Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1965 1
1970 1
1972 1
1974 2
1976 1
1977 1
1980 1
1982 2
1985 1
1987 1
1988 1
1989 1
1990 4
1991 1
1992 3
1994 1
1995 1
1996 3
1997 2
1999 2
2000 2
2001 3
2002 4
2003 3
2004 3
2005 3
2006 4
2007 3
2008 5
2009 2
2010 3
2011 4
2012 3
2013 3
2014 5
2015 6
2016 5
2017 6
2018 3
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31501179

102 results
Results by year
Filters applied: . Clear all
Page 1
Streamlining the management of Parkinson disease in Canada.
Bruno V, de Freitas MET. Bruno V, et al. CMAJ. 2019 Sep 9;191(36):E979-E980. doi: 10.1503/cmaj.191089. CMAJ. 2019. PMID: 31501179 Free PMC article. No abstract available.
No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.
Umeh CC, Pérez A, Augustine EF, Dhall R, Dewey RB Jr, Mari Z, Simon DK, Wills AM, Christine CW, Schneider JS, Suchowersky O. Umeh CC, et al. PLoS One. 2014 Dec 8;9(12):e112287. doi: 10.1371/journal.pone.0112287. eCollection 2014. PLoS One. 2014. PMID: 25486269 Free PMC article. Clinical Trial.
[Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
Alegre M, Noé E, Martínez Lage JM. Alegre M, et al. Neurologia. 1997 Nov;12(9):429. Neurologia. 1997. PMID: 9471184 Spanish. No abstract available.
Abstracts of the Third World Parkinson Congress. October 1-4, 2013. Montréal, Canada.
[No authors listed] [No authors listed] J Parkinsons Dis. 2013;3 Suppl 1:3-252. doi: 10.3233/JPD-139905. J Parkinsons Dis. 2013. PMID: 24025747 No abstract available.
Canadian guideline for Parkinson disease.
Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, Suchowersky O, Rajput A, Lafontaine AL, Mestre T, Appel-Cresswell S, Kalia SK, Schoffer K, Zurowski M, Postuma RB, Udow S, Fox S, Barbeau P, Hutton B. Grimes D, et al. CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504. CMAJ. 2019. PMID: 31501181 Free PMC article. No abstract available.
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.
Etminan M, Carleton BC, Samii A. Etminan M, et al. J Clin Neurosci. 2008 May;15(5):576-7. doi: 10.1016/j.jocn.2007.02.095. Epub 2008 Mar 14. J Clin Neurosci. 2008. PMID: 18343119
"Stiff in the closet"--who provides care for Parkinsonian patients?
Stoessl AJ. Stoessl AJ. Can J Neurol Sci. 2002 Aug;29(3):203-4. doi: 10.1017/s0317167100001943. Can J Neurol Sci. 2002. PMID: 12195607 No abstract available.
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators. Parashos SA, et al. Arch Neurol. 2009 Sep;66(9):1099-104. doi: 10.1001/archneurol.2009.159. Epub 2009 Jul 13. Arch Neurol. 2009. PMID: 19597081 Free PMC article. Clinical Trial.
Entacapone: adjunctive use in patients with advanced Parkinson's disease.
McAuley L. McAuley L. Issues Emerg Health Technol. 2000 Dec;(12):1-7. Issues Emerg Health Technol. 2000. PMID: 11902220 No abstract available.
Impact of Two Different Antimicrobial Stewardship Methods on Frequency of Streamlining Antimicrobial Agents in Patients with Bacteremia.
Lukaszewicz Bushen J, Mehta JM, Hamilton KW, Shawn Binkley, Timko DR, Lautenbach E, Pegues DA. Lukaszewicz Bushen J, et al. Infect Control Hosp Epidemiol. 2017 Jan;38(1):89-95. doi: 10.1017/ice.2016.243. Epub 2016 Nov 9. Infect Control Hosp Epidemiol. 2017. PMID: 27825392
102 results
Jump to page
Feedback